AstraZeneca is collaborating with UK-based Orca Pharmaceuticals to develop new drugs for a wide range of autoimmune diseases. The companies announced a three year collaboration to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (RORγ), which is believed to have potential against a wide range of autoimmune diseases for …